-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Raises Price Target to $45

Benzinga·12/11/2025 11:29:43
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price target from $36 to $45.